Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,745 DKK | -1.88% |
|
-3.38% | -19.03% |
28/06 | Would you like some more inflation? | ![]() |
28/06 | Genmab, AbbVie's Lymphoma Therapy Recommended for Approval in EU | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.03% | 1.59TCr | |
+15.20% | 12TCr | |
+19.67% | 11TCr | |
+18.95% | 2.6TCr | |
-23.86% | 1.94TCr | |
-20.90% | 1.51TCr | |
-46.14% | 1.51TCr | |
+63.85% | 1.49TCr | |
+4.49% | 1.39TCr | |
+116.20% | 1.08TCr |
- Stock Market
- Equities
- GMAB Stock
- News Genmab A/S
- Genmab Wins US Approval for Follicular Lymphoma Treatment